Rchr
J-GLOBAL ID:202001015990561633   Update date: Feb. 01, 2024

Katayama Saori

カタヤマ サオリ | Katayama Saori
Affiliation and department:
Homepage URL  (1): https://www.ped.med.tohoku.ac.jp/
Research field  (2): Hematology and oncology ,  Fetal medicine/Pediatrics
Research keywords  (3): 先天性血小板減少症 ,  血液腫瘍 ,  小児がん
Research theme for competitive and other funds  (2):
  • 2022 - 2025 遺伝性血小板減少症の新規原因遺伝子を介した巨核球・血小板造血メカニズムの解明
  • 2018 - 2020 Elucidate the importance of MPL in the pathogenesis of hematological diseases caused by abnormal EVI1 expression
Papers (36):
  • Akira Kaino, Hidetaka Niizuma, Saori Katayama, Masahiro Irie, Tomohiro Nakano, Daichi Sato, Tsuyoshi Saito, Shunsuke Kato, Yoshiyuki Suehara, Yoji Sasahara, et al. Two-year crizotinib monotherapy induced durable complete response of pediatric ALK-positive inflammatory myofibroblastic tumor. Pediatric blood & cancer. 2023. 70. 8. e30330
  • Chihaya Imai, Atsushi Sato, Mitsuteru Hiwatari, Yasuto Shimomura, Toshinori Hori, Souichi Suenobu, Toshihiko Imamura, Junichi Hara, Daisuke Hasegawa, Hiroyuki Takahashi, et al. Outcomes following induction failure in Japanese children with acute lymphoblastic leukemia. International journal of hematology. 2023. 118. 1. 99-106
  • Masahiro Irie, Tetsuya Niihori, Tomohiro Nakano, Tasuku Suzuki, Saori Katayama, Kunihiko Moriya, Hidetaka Niizuma, Nobu Suzuki, Yuka Saito-Nanjo, Masaei Onuma, et al. Reduced-intensity conditioning is effective for allogeneic hematopoietic stem cell transplantation in infants with MECOM-associated syndrome. International journal of hematology. 2022. 117. 4. 598-606
  • Taichi Fukuzawa, Yuki Endo, Masahiro Irie, Hideyuki Sasaki, Hironori Kudo, Megumi Nakamura, Ryo Ando, Ryuji Okubo, Tsuyoshi Sakurai, Masatoshi Hashimoto, et al. Type II pleuropulmonary blastoma with DICER1 mutation. Journal of Pediatric Surgery Case Reports. 2022. 87. 102468-102468
  • Miyu Sai, Hidetaka Niizuma, Kohei Yagi, Tomohiro Nakano, Saori Katayama, Noriko Himori, Masahiro Irie, Yoji Sasahara. Comprehensive genomic profiling suggested multifocal development of retinoblastoma in a single eye. Pediatric blood & cancer. 2022. e30031
more...
MISC (69):
  • Akira Kaino, Keita Tagami, Mamiko Sato, Saori Katayama, Tasuku Suzuki, Kunihiko Moriya, Masahiro Irie, Hidetaka Niizuma, Akira Inoue, Yoji Sasahara. HOW PALLIATIVE CARE TEAM SUPPORT US PEDIATRICIANS. CASE REPORTS AND COOPERATIVE WORKS FROM TOHOKU UNIVERSITY HOSPITAL. PEDIATRIC BLOOD & CANCER. 2022. 69
  • 中村 春彦, 入江 正寛, 片山 紗乙莉, 森谷 邦彦, 力石 健, 新妻 秀剛, 笹原 洋二, 呉 繁夫. 術前化学療法を施行した両側性Wilms腫瘍の2例. 日本小児血液・がん学会雑誌. 2022. 59. 2. 202-203
  • 目黒美結, 森谷邦彦, 崔実結, 戒能明, 片山紗乙莉, 鈴木資, 入江正寛, 新妻秀剛, 笹原洋二, 呉繁夫. 化学療法後好中球減少症を合併し画像診断により肛門周囲感染症を疑った1例. 小児科. 2022. 63. 2
  • 森谷邦彦, 今村俊彦, 片山紗乙莉, 戒能明, 岡本賢治, 横山能文, 植村優, 北澤宏展, 関水匡大, 平松英文, et al. Incidence of symptomatic ON in pediatric ALL treated with BFM based protocol is similar to children in western countries. 日本小児科学会雑誌. 2022. 126. 2
  • Masahiro Irie, Yoji Sasahara, Tomohiro Nakano, Tasuku Suzuki, Saori Katayama, Kunihiko Moriya, Hidetaka Niizuma, Takeshi Rikiishi, Masashi Hirayama, Shigeo Kure. A Case Report of 8 Year-Old Girl with MDS, Suffering from SOS After Allogeneic BMT, Followed by Post-Transplantation Thrombocytopenia. PEDIATRIC BLOOD & CANCER. 2021. 68
more...
Lectures and oral presentations  (8):
  • Genetic analysis of an early T-cell precursor acute lymphoblastic lymphoma associated with myeloproliferative neoplasm
  • 自己免疫症状に対してリツキシマブを使用したWiskott-Aldrich症候群の3例
    (第122回日本小児科学会学術集会 2019)
  • GATA2 haploinsufficiency accelerates EVI1-driven leukemogenesis in an inv(3)(q21q26) mouse model
    (第60回日本小児血液・がん学術集会 2018)
  • GATA2 haploinsufficiency accelerates EVI1-driven leukemogenesis in an inv(3)(q21q26) mouse model
    (第14回血液学若手研究者勉強会(麒麟塾) 2018)
  • GATA2遺伝子ヘテロ欠失は3番染色体逆位を伴う白血病の発症を促進する
    (第89回日本生化学会大会 2016)
more...
Professional career (1):
  • 博士(医学) (東北大学)
Awards (2):
  • 2018/11 - 一般社団法人 日本小児血液・がん学会 第8回日本小児血液・がん学会学術賞 GATA2 haploinsufficieny accelerates EVI1-driven leukemogenesis
  • 2016/09 - 公益社団法人 日本生化学会 第89回日本生化学会大会若手優秀発表賞 GATA2遺伝子ヘテロ欠失は3番染色体逆位を伴う白血病の発症を促進する
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page